The expression of TRPC3 (canonical-type transient receptor potential cation channel type 3) is tightly regulated during skeletal muscle cell differentiation, and a functional interaction between TRPC3 and RyR1 [(ryanodine receptor type 1), an SR (sarcoplasmic reticulum) Ca 2+ -release channel] regulates the gain of SR Ca 2+ release during EC (excitation-contraction) coupling. However, it has not been possible to demonstrate direct protein-protein interactions between TRPC3 and RyR1. To identify possible candidate(s) for a linker protein(s) between TRPC3 and RyR1 in skeletal muscle, in the present study we performed MALDI-TOF (matrix-assisted laser-desorption ionization-time-of-flight) MS analysis of a cross-linked triadic protein complex from rabbit skeletal triad vesicles and co-immunoprecipitation assays using primary mouse skeletal myotubes. From these studies, we found that six triadic proteins, that are known to regulate RyR1 function and/or EC coupling [TRPC1, JP2 (junctophilin 2), homer, mitsugumin 29, calreticulin and calmodulin], interacted directly with TRPC3 in a Ca 2+ -independent manner. However we again found no direct interaction between TRPC3 and RyR1. TRPC1 was identified as a potential physical link between TRPC3 and RyR1, as it interacted with both TRPC3 and RyR1, and JPs showed subtype-specific interactions with both RyR1 and TRPC3 (JP1-RyR1 and JP2-TRPC3). These results support the hypothesis that TRPC3 and RyR1 are functionally engaged via linker proteins in skeletal muscle.
INTRODUCTION
The TRPC (canonical-type transient receptor potential cation channel) family in mammals is highly related to Drosophila TRP, which plays an essential role in photoreceptor signal transduction pathways [1, 2] . The TRPC family is composed of seven TRPC subtypes, which act as non-selective cation channels, allowing Ca 2+ and Na + entry into cells. All seven TRPC subtypes have six plasma membrane-spanning (transmembrane) segments, a putative pore region between their fifth and sixth transmembrane segments, four ankyrin repeats in their N-terminus, and a TRP box (EWKFAR) in their C-terminus.
TRPC3 is expressed in various organs and systems, including the immune system, cardiovascular system, skeletal muscle, the reproductive system, kidney and the endocrine system [2] [3] [4] [5] [6] [7] . TRPC3 is involved in two Ca 2+ -entry pathways. First, it is involved in ROCE (receptor-operated Ca 2+ entry). Receptor activation by agonists in turn activates PLC (phospholipase C). PLC then produces DAG (diacylglycerol) from PIP 2 (phosphatidylinositol 4,5-bisphosphate), and DAG binds to TRPC3, allowing Ca 2+ entry. Secondly, TRPC3 participates in SOCE (store-operated Ca 2+ entry) where it is activated secondarily to Ca 2+ depletion in the ER (endoplasmic reticulum)/SR (sarcoplasmic reticulum) by the activation of internal Ca 2+ channels, such as the IP 3 Rs [IP 3 (inositol 1,4,5-trisphosphate) receptors] and RyRs (ryanodine receptors), and allows Ca 2+ entry to help replenish the stores and/or maintain a sustained Ca 2+ elevation in cytoplasm. The mechanism signalling SOCE is still uncertain. Possible factors linking ER/SR Ca 2+ depletion and the activation of TRPC3 in SOCE could include the following [2, [4] [5] [6] [7] [8] [9] : release of CIF (calcium-induced factor) from the ER; fusion of TRPC3-transporting vesicles to the plasma membrane; migration of STIM1 (stromal interaction molecule 1) expressed in the ER/SR membrane as an ER/SR Ca 2+ sensor to the plasma membrane; Orai 1 as a subunit to form Ca 2+ -release-activated Ca 2+ current (I CRAC ) channels; and, a possible direct interaction between internal Ca 2+ channels and TRPC3. It is important to note that almost all of the studies that have shown the possible interactions between TRPC3 and ER/SR Ca 2+ -release channels have been performed in heterologous expression systems, such as HEK (human embryonic kidney)-293 cells, but not in bona fide TRPC3-expressing systems, such as primary murine muscle cells.
RyR1 is the primary Ca 2+ -release channel in the SR of striated muscles, and is an essential protein for EC (excitationcontraction) coupling [10, 11] . In skeletal muscle, the DHPR (dihydropyridine receptor) undergoes conformational changes in response to membrane depolarization and this changed state physically interacts with RyR1 (called 'occupied RyR1'). This interaction activates RyR1 to release Ca 2+ ions from the SR into the cytoplasm for muscle contraction.
Recently, the significance of extracellular Ca 2+ entry in many cellular events has been recognized because it is now known that in many Ca 2+ -dependent cellular events, the source of Ca
2+
ions is derived not only from internal Ca 2+ stores but from the extracellular Ca 2+ pool that is also recruited to maintain a sustained elevation in cytoplasmic Ca 2+ concentration. Through its role as a mediator of extracellular Ca 2+ entry, TRPC3 has been shown to regulate multiple physiological processes such Abbreviations used: bFGF, basic fibroblast growth factor; BMH, 1,6-bismaleimidohexane; CaM, calmodulin; CaMKII, CaM kinase II; DAG, diacylglycerol; DHPR, dihydropyridine receptor; DMEM, Dulbecco's modified Eagle's medium; EC, excitation-contraction; ER, endoplasmic reticulum; FBS, fetal bovine serum; FKBP12, FK506-binding protein 12; HEK, human embryonic kidney; IEF, isoelectric focussing; IPG, immobilized pH gradient; IP 3 R, inositol 1,4,5-trisphosphate receptor; JP, junctophilin; MALDI-TOF, matrix-assisted laser-desorption ionization-time-of-flight; MG29, mitsugumin 29; PBST, PBS with 0.1 % Tween 20; PLC, phospholipase C; RyR, ryanodine receptor; SOCE, store-operated Ca 2+ entry; SR, sarcoplasmic reticulum; STIM1, stromal interaction molecule 1; TRPC, canonical-type transient receptor potential cation channel. 1 To whom correspondence should be addressed (email EHUI@catholic.ac.kr).
as: growth cone guidance and synaptic plasticity in the central nervous system [12] ; blood vessel constriction and arterial hypertension in the circulatory system [13, 14] ; differentiation of immune cells [15] ; abnormal Ca 2+ entry into dystrophic mouse skeletal muscle fibres [3] ; and full gain of EC coupling in primary mouse skeletal myotubes [7] . However, how TRPC3 is activated during various cellular events and which other proteins are involved in TRPC3 activation have not yet been determined. A direct interaction between TRPC3 and IP 3 R has been proposed as an explanation for how ER Ca 2+ -store depletion induces TRPC3 activation in heterologous expression systems (HEK-293 cells or DT40 avian B lymphocytes) [16] [17] [18] . An interaction between TRPC3 and RyRs has also been proposed, but there are conflicting reports. In HEK-293 cells, heterologously expressed TRPC3 has been shown to interact directly with RyR1 [19] . In a previous study by our group, TRPC3-knockdown in primary mouse skeletal myotubes significantly reduced the amplitude of SR Ca 2+ release (> 40 %) both during EC coupling and when it is induced by a direct RyR1 agonist (40 mM caffeine) [7] , suggesting that TRPC3 and RyR1 are functionally engaged. However, in the same study we found that TRPC3 is not co-localized with RyR1 in wild-type skeletal myotubes, and others have shown a lack of co-localization of TRPC3 with RyR2 in transverse sections through heart muscle or in single isolated adult cardiomyocytes [20] .
To determine whether or not this functional interaction between TRPC3 and RyR1 is the result of a direct interaction or whether the interaction is the result of an indirect linkage via physical linker protein(s), we investigated RyR1-and TRPC3-interacting proteins in triad vesicles from rabbit skeletal muscle and primary mouse skeletal myotubes. We found that in skeletal myotubes (i) TRPC3 and RyR1 appear to interact indirectly via a linker protein, TRPC1, and (ii) several triadic proteins which are important for EC coupling interact directly with TRPC3 such as JP2 (junctophilin 2), CaM (calmodulin), calreticulin, homer and MG29 (mitsugumin 29) and as such may act as possible coregulatory proteins of the interaction between TRPC3 and RyR1.
EXPERIMENTAL

Materials
FBS (fetal bovine serum), cell culture media, L-glutamine, penicillin/streptomycin and bFGF (basic fibroblast growth factor) were obtained from Invitrogen. Monoclonal anti-RyR1 antibody (34C, against purified α and β RyRs from chicken skeletal muscle; used at 1:5000 for immunoblot and 1:420 for co-immunoprecipitation assays) was provided by Dr J. Airey and Dr J. Sutko (Developmental Studies Hybridoma Bank, Iowa City, IA, U.S.A.). Polyclonal anti-TRPC1 (against a peptide corresponding to amino acid residues 557-571 of human TRPC1; used at 1:800 for immunoblot and 1:250 for co-immunoprecipitation assays) and polyclonal anti-TRPC3 antibodies (against a peptide corresponding to amino acid residues 822-835 of human TRPC3; used at 1:800 for immunoblot and 1:250 for co-immunoprecipitation assays) were obtained from Alomone Laboratories. Anti-triadin (used at Trypsin, BMH (1,6-bismaleimidohexane) and DMSO were obtained from Pierce.
Cell cultures
The methods used to derive primary wild-type myoblasts from mouse skeletal muscle and an RyR1/2/3-null myoblast cell line (1B5 cells) have been described previously [21, 22] . Primary wildtype or 1B5 myoblasts were plated on to 10-cm dishes coated with collagen for primary wild-type myoblasts and Matrigel for RyR-null myoblasts. Cells were cultured at 37
• C in a 5% CO 2 incubator in a growth medium [for primary wild-type myoblast this was low-glucose DMEM (Dulbecco's modified Eagle's medium) containing 20 % FBS, 100 units/ml penicillin, 100 µg/ml streptomycin, an additional 2 mM L-glutamine and 20 nM bFGF; and for RyR-null myoblasts this was the same growth medium except high-glucose DMEM was used without the addition of bFGF). When cells reached ≈ 70 % confluence, the growth medium was replaced with differentiation medium (5 % heat-inactivated horse serum was substituted for 20 % FBS in the RyR-null myoblast growth medium), and the cells were placed in an 18 % CO 2 incubator to induce differentiation. The differentiated myotubes were subjected to an immunoblot or a co-immunoprecipitation assay.
Co-immunoprecipitation assay
Co-immunoprecipitation assays were performed using a procedure described previously [7, 23] . Briefly, myotubes were homogenized and solubilized with a lysis buffer [1 % Triton X-100, 10 mM Tris/HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA (or 100 µM Ca 2+ ), 1 mM Na 3 VO 4 , 10% glycerol, 1 mM PMSF, 20 µg/ml aprotinin, 12.5 µg/ml leupeptin and 20 µg/ml pepstatin A] to prepare the cell lysate (200 µl of lysis buffer was added per 10-cm culture dish). The 100 µM free Ca 2+ concentration in the lysis buffer was set by adding 5 mM CaCl 2 . The solubilized lysate was then centrifuged at 1500 g for 30 s to remove insolubilized matter. The lysate (500 µg of protein) was incubated with 25 µl of anti-TRPC1 antibody, 25 µl of anti-TRPC3 antibody or 15 µl of anti-RyR1 antibody overnight at 4
• C, followed by additional incubation with Protein A-(for polyclonal antibodies) or Protein G-(for the monoclonal antibody) Sepharose 4 fast flow affinity beads for 4 h. Protein-bead complexes were washed three times with PBS to remove non-specific binding and were treated with SDS-sample buffer for SDS/PAGE and immunoblot analysis with various antibodies.
Preparation of triad vesicles
Triad vesicles were prepared from rabbit fast-twitch muscle (back and leg), using a procedure described previously [23] . Solubilization of triad vesicles was conducted as described above for the solubilization of myotubes in the co-immunoprecipitation assay.
All surgical interventions and presurgical and postsurgical animal care were provided in accordance with the Laboratory Animals Welfare Act, the Guide for the Care and Use of Laboratory Animals and the Guidelines and Policies for Rodent Survival Surgery provided by IACUC (Institutional Animal Care and Use Committee) in College of Medicine, The Catholic University of Korea, Korea.
Cross-linking of triadic proteins
For cross-linking triadic proteins using BMH, triad vesicles (200 µg of protein, 435 µl of 0.46 µg/µl triad vesicle sample) were incubated with 0.5 mM BMH (0.22 µl of 1 M BMH dissolved in DMSO, DMSO 0.05 %) at 4
• C with gentle agitation for 1 h to avoid non-specific cross-links. As a negative control, the same amount of DMSO without BMH was incubated with triad vesicles.
One-or two-dimensional gel electrophoresis
The BMH-derived triadic protein complexes were either separated by molecular mass using SDS/PAGE (8 % gels for RyR1; 10 % gels for TRPC1, TRPC3, triadin, homer, JP1 and JP2; 15 % gels for CaM, MG29, FKBP12 and CaMKII), or were absorbed on to 13-cm IPG (immobilized pH gradient) strips (pH 3-10) and then subjected to IEF (isoelectric focussing) on an IPGphor IEF unit to be separated by pI. The focussed IPG strips were then subjected to SDS/PAGE (12 % gels) to be separated by their molecular mass. For both assays, gels were visualized by silver staining. For immunoblot analysis, the proteins on the gel were transferred on to nitrocellulose membrane at 100 V for 2 h. The membranes were incubated with one of the antibodies described above, washed with PBST (PBS with 0.1 % Tween 20), and then incubated with horseradish peroxidase-conjugated goat anti-mouse (1:20 000) or anti-rabbit (1:20 000) antibodies for 45 min at room temperature (25
• C). The membranes were washed three times with PBST and developed using SuperSignal ultrachemiluminescent substrate (Pierce).
Trypsin digestion and MALDI-TOF (matrix-assisted laser-desorption ionization-time-of-flight) MS analysis
Common procedures, which have been described in detail previously [24] , were used for MALDI-TOF analysis. Briefly, the band for the BMH-derived ultra-mass triadic protein complex in Figure 2 was cut from the gel and dehydrated in MeCN for 10 min. The gel piece was covered with 10 mM DTT (dithiothreitol) in NH 4 HCO 3 (100 mM) for 1 h at 56
• C to reduce proteins. The mixture was cooled to room temperature and incubated with 55 mM iodoacetamide in 100 mM NH 4 HCO 3 for 45 min in a dark place at room temperature after removing the reducing buffer (three repetitions of the washing and dehydration cycle). The gel piece was digested with trypsin (12.5 ng/µl trypsin per 5 µl/mm 2 gel) at 37
• C overnight. The gel slice was centrifuged (7000 g for 1 min at 25
• C) and the supernatant was collected. Trypsindigested peptides in the supernatant were further extracted by one change of 20 mM NH 4 HCO 3 and three changes of 5 % formic acid in 50 % CH 3 CN (20 min between changes) at 25
• C. MALDI-TOF MS analysis was performed with the extracted trypsin-digested peptides using Voyager-DE STR from Applied Biosystems. α-Cyano-4-hydroxycinnamic acid (0.5 µl, 10 mg/ml) was used as the matrix for each sample (0.5 µl). In the reflector mode, 20 000 V of accelerating voltage and 200 ns of extraction delay time were applied. The laser intensity was 1900-2300, and 100-200 laser shots were collected for each spectrum. The acquisition mass range was 750-4500 Da with a 600 Da low-mass gate. The MS data obtained from analysing the extracted trypsin-digested peptides were fitted to data from protein sequences in an existing database using a program, MS-Fit (+ − 50 p.p.m. mass tolerance with homology search mode) from the University of California San Francisco, Mass Spectrometry Facility (San Francisco, CA, U.S.A.). Only proteins showing more than 50 % of sequence coverage (the number of matching peptides with trypsin-digested peptides for the BMH-derived ultra-mass triadic protein complex/the total number of trypsindigested peptides for a given protein) were considered.
Figure 1 TRPC3 expression gradually decreases after an initial peak in expression during differentiation of RyR-null (1B5) myoblasts
Expression levels of TRPC3 during differentiation of RyR-null (1B5) myoblasts were examined by immunoblot analysis (upper panel). The expression level of TRPC3 on each day (from D0 to D5) was normalized to the expression level of α-tubulin on the same day and then normalized again by the level on day zero (D0) (bottom panel). D0-D5 represents the differentiation from day zero to day five. *Significant difference compared with D0 (myoblast) (P < 0.05). Values are means + − S.E.M. of three independent experiments.
Statistical analysis
Results are given as means + − S.E.M. of at least three independent experiments. Significant differences were analysed using a paired t test (GraphPad InStat, v2.04). Differences were considered to be significant at P < 0.05. Graphs were prepared using Origin v7.
RESULTS AND DISCUSSION
In the present study, expression levels of TRPC3 were examined during differentiation of RyR-null (1B5) mouse skeletal myoblasts. The expression level of TRPC3 gradually decreased during differentiation after an initial peak (Figure 1 ). The same pattern was observed during differentiation of primary wild-type mouse skeletal myoblasts in our previous study [7] . However, the expression level of TRPC3 on each day of RyR-null cell differentiation was significantly lower than that of primary wildtype cells: at least 2.2-fold less expression of TRPC3 in the absence of RyRs (Table 1 ). In the case of TRPC3-knockdown in primary wild-type mouse skeletal myotubes, the expression level of RyR1 was not significantly changed, but SR Ca 2+ release through RyR1 during EC coupling was reduced [7] . The results from RyR-null and TRPC3-knockdown cells suggest that there may be bidirectional communication between TRPC3 and RyR1 during Ca 2+ -mediated cellular events, such as muscle cell differentiation and contraction.
To examine whether TRPC3 and RyR1 interact with each other directly or if they require other protein(s) to link them, a broad search for RyR1-interacting/close triadic proteins (proteins that exist in/around triad junctions composed of SR and ttubular membranes) was conducted using a chemical crosslinking study. The hypothesis was that if TRPC3 and RyR1 are close enough to interact directly, then they may be able 
Figure 2 Cross-linking of triadic proteins by BMH
The chemical formula of BMH is presented in the inset. Triadic proteins cross-linked by BMH (Triad + BMH) were subjected to SDS/PAGE and then silver-stained. A dominant ultra-mass triadic protein complex appeared as a result of cross-linking (indicated by an arrow and zoomed-in view). DMSO-treated triadic proteins (Triad) were used as a negative control.
to be linked by chemical cross-linkers. One of chemical crosslinkers, BMH, resulted in irreversible cross-linking of sulfhydrylcontaining protein(s), due to its homo-bifunctional maleimide groups with a 13.0 Å (1 Å = 0.1 nm) spacer arm [24] (Figure 2 ). Triad vesicles from rabbit skeletal muscle were incubated with 0.5 mM BMH (dissolved in DMSO, 0.05 %) at 4 • C with gentle agitation for 1 h to avoid non-specific cross-links and then subjected to SDS/PAGE followed by silver-staining ( Figure 2) . As a result of the cross-linking, high-molecularmass complexes appeared; notably, an ultra-mass triadic protein complex was evident (indicated by the arrow and zoomed-in view). Considering that TRPC3 and RyR1 are high-molecularmass proteins (> 92 kDa and 560 kDa respectively), it is possible that the BMH-derived ultra-mass triadic protein complex contains TRPC3, RyR1 or both. Two-dimensional gel electrophoresis and silver staining showed a more detailed rearrangement of triadic proteins due to the cross-linking (see Supplementary Figure 1 at http://www.BiochemJ.org/bj/411/bj4110399add.htm): proteins with neutral to basic pI values for the most part disappeared (indicated by red arrows), and high molecular mass and more acidic proteins appeared instead (indicated by green arrows). To examine the identity of the BMH-derived ultra-mass triadic protein complex in Figure 2 , the protein complex band was excised and subjected to trypsin digestion followed by MALDI-TOF MS analysis. In addition to finding RyR1, several triadic proteins that are known to interact with or regulate RyR1 function, such as DHPR, junctin, triadin, JP1, protein kinase C, CaMKII and cGMP-dependent protein kinase [7, 25, 26] , were all identified in the analysis of the ultra-mass triadic protein complex (see Supplementary Figure 2 at http://www.BiochemJ.org/bj/411/ bj4110399add.htm). Also in this complex, other possible triadic RyR1-interacting/regulating proteins were included, such as TRPC1, TRPC5, TRPV1, TRPV6, PLC and EBP50 (ezrinradixin-moesin-binding phosphoprotein 50), but TRPC3 was not included. Because of the limited length of the BMH spacer arm (13.0 Å) and its limited reactivity (only with sulfhydrylcontaining proteins at their accessible surface), not all proteins with the potential to interact with RyR1 could be cross-linked using this method.
To be more specific for finding TRPC3-interacting triadic protein(s), solubilized samples from primary wild-type mouse skeletal myotubes were immunoprecipitated with the anti-TRPC3 antibody, and the immune complex of TRPC3 was subjected to immunoblot analysis with various anti-triadic protein antibodies (Figure 3) . Samples without anti-TRPC3 antibody or with a blocking peptide corresponding to the epitope of anti-TRPC3
Figure 3 TRPC3-interacting triadic proteins
Solubilized primary wild-type myotubes were subjected to a co-immunoprecipitation assay with an anti-TRPC3 antibody and then immunoblot analysis with various anti-triadic protein antibodies. Among 11 triadic proteins, TRPC1, calreticulin, CaM, homer, JP2 and MG29 were successfully co-immunoprecipitated with TRPC3 in a Ca 2+ -independent manner. To show the specificity of the anti-TRPC3 antibody to recognize TRPC3 protein, samples without anti-TRPC3 antibody (Input) served as negative controls (shown in Supplementary  Figure 3 at http://www.BiochemJ.org/bj/411/bj4110399add.htm). IP, immunoprecipitation; IB, immunoblot.
antibody (H 822 KLSEKLNPSVLRC 835 ) served as negative controls (see Supplementary Figure 3 at http://www.BiochemJ.org/bj/ 411/bj4110399add.htm). Among the 11 triadic proteins tested, TRPC1, calreticulin, CaM, homer, JP2 and MG29 could be coimmunoprecipitated with TRPC3 in a Ca 2+ -independent manner. In accordance with results from the cross-linking and MALDI-TOF MS analysis, RyR1 was not co-immunoprecipitated with TRPC3 in the presence or absence of Ca 2+ . However, direct interaction between TRPC3 and RyR1 has been reported in TRPC3-overexpressing HEK-293 cells [19] and in RyR-null myotubes overexpressing RyR1 [27] . Therefore the discrepancy between the present results for wild-type primary myotubes and our previous findings may be explained by the mass action of overexpressed and enriched TRPC3s or RyR1s in the test systems.
TRPC1 was one of the most interesting proteins that interacted with TRPC3 because TRPC1 also was shown to interact with RyR1 in our cross-linking and MALDI-TOF MS analysis ( Figure 3 and Supplementary Figure 2) . Co-immunoprecipitation assays of TRPC1 and RyR1 with an anti-RyR1 antibody ( Figure 4A ) or an anti-TRPC1 antibody ( Figure 4B ) in solubilized primary wild-type mouse skeletal myotubes confirmed these results, suggesting that TRPC1 co-interacts with both TRPC3 and RyR1. However, with this method it remains to be determined whether or not TRPC1 interacts with only 'orphan' RyR1s that are not directly associated with DHPRs or all RyR1s. The same experiments with solubilized RyR-null myotubes instead of primary wild-type myotube were conducted as negative controls, shown in Supplementary Figure 4 (at http://www.BiochemJ.org/ bj/411/bj4110399add.htm). TRPC1 has been reported to form heteromeric channels with TRPC3 in HEK-293 [28] and HSY cells [29] ; with TRPC3 and TRPC4 in mature platelets and in megakaryocytic cells [30] ; with TRPC3 and TRPC5 in the embryonic brain [31] ; and with TRPC3 and TRPC7 in HEK-293 cells [32] . STIM1 has also been reported to mediate heteromeric TRPC1/3 formation [33, 34] . Therefore a plausible explanation for the role of TRPC1 as a physical link between TRPC3 and RyR1 is that TRPC1 forms heteromeric channels with TRPC3 and at the same time interacts with RyR1. In support of this, TRPC3 knockdown (> 97 %) in primary wild-type mouse skeletal myotubes increased TRPC1 expression almost 2-fold [7] , possibly as a compensatory mechanism for the missing TRPC3. In addition, there have been other reports demonstrating a functional interaction between TRPC1 and TRPC3, including an increased expression of TRPC1 with TRPC3 after prolonged ER depletion (24-48 h) in an androgen-responsive prostate cancer cell line (LNCaP) [35] and a tandem action of TRPC1 and TRPC3 in rat hippocampal neuronal cells during differentiation [36] .
JPs are single transmembrane proteins in the SR membrane and contribute to the formation of triad junctions in excitable cells by both interacting with t-tubular membranes via their Nterminus and by spanning SR membranes via their C-terminus [26, 37] . JP1 has been shown to directly interact with RyR1 [7] , a finding that we confirmed by cross-linking and MALDI-TOF mass spectrometric analysis. However, it was JP2, rather than JP1, that co-immunoprecipitated with TRPC3, suggesting that JPs have subtype-specific interactions with either RyR1 or TRPC3 (JP1-RyR1 and JP2-TRPC3). Four other triadic proteins, homer, CaM, MG29 and calreticulin, also were found to be TRPC3-interacting proteins in the co-immunoprecipitation assay (Figure 3) . It has been shown that the intrinsic activity of TRPC3 is inhibited by the binding of Ca 2+ /CaM [16] . The Ca 2+ /CaM-binding site on TRPC3 overlaps with the TRPC3-binding domain for IP 3 R whose binding induces the activation of TRPC3 [38] . Regardless of the binding of Ca 2+ /CaM or IP 3 R, the Ca 2+ /CaM-binding site on TRPC3 is involved in its targeting to the plasma membrane [39] . In HEK-293 cells, TRPC3-homer1b-c-IP 3 R complexes mediate both the translocation of TRPC3-containing vesicles to the plasma membrane and gating of TRPC3 by IP 3 R. [40] . However, in the case of MG29 and calreticulin, their functional relevance to TRPC3 activity remains to be elucidated.
In summary, using two bona fide TRPC3-expressing systems, triad vesicles from rabbit skeletal muscle and primary mouse skeletal myotubes instead of heterologous or homologous overexpression systems, we discovered six or more RyR1-or TRPC3-interacting triadic proteins by using a co-immunoprecipitation assay after establishing potential candidate proteins with chemical cross-linking of triadic proteins and MALDI-TOF MS analysis. These results suggest that in muscle, TRPC3 and RyR1 interact indirectly via a linker protein, TRPC1. In addition, JP, homer, CaM, MG29 and calreticulin appear to be possible co-regulatory proteins of both TRPC3 and RyR1.
